• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    OncXerna Announces Final Results from PII Trial of Bavituximab & Pembrolizumab

    23 Jan 2023 //

    GLOBENEWSWIRE

    OncXerna Therapeutics Announces New Xerna™ TME Panel Biomarker Data

    12 Sep 2022 //

    GLOBENEWSWIRE

    OncXerna doses first subject to evaluate navicixizumab in Phase II trial

    09 Sep 2022 //

    CLINICALTRIALSARENA

    OncXerna Therapeutics Doses First Patient in Ph2 Trial Evaluating Navicixizumab

    08 Sep 2022 //

    GLOBENEWSWIRE

    OncXerna`s Upcoming ASCO Poster Featuring Data of PII Glioblastoma Trial

    03 Jun 2022 //

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.